the ocular hypotensive effect of tafluprost (Tapros)

the ocular hypotensive effect of tafluprost (Tapros) - The efficacy of tafluprost

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001693

Enrollment

Registered

2009-02-20

Start date

2009-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

latanoprost tafluprost

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: normal volunteers

Exclusion criteria

Exclusion criteria: 1)abnormal finding revealed by the ophthalmological examination 2)history of ocular disease 3)previous eye surgery 4)suspected allergic reactions to the study drugs 5)inability to follow the protocol

Design outcomes

Primary

Measure	Time frame
intraocular pressure	—

Secondary

Measure	Time frame
adverse effect of ocular surface	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026